The European Access Academy (EAA) aims to identify key challenges and provide sound input for the implementation of the EU HTA Regulation to help achieve the EC’s mission of improving patient access to life saving innovative technologies.

The EAA Faculty is acting as Steering Committee for the EAA's work, providing guidance on strategy, supporting peer-reviewed publications and ensuring scientific integrity. As such, it is listed in the EU Transparency Registry and was accepted as a member of the European Commission's HTA Stakeholder Network.